Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Michigan › Lansing

Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Lansing, MI

4 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Lansing (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

Ap rekriteFaz 3

University of Michigan Health - Sparrow Lansing, Lansing

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06524544

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2

University of Michigan Health - Sparrow Lansing, Lansing

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Ap rekriteFaz 2

Karmanos Cancer Institute at McLaren Greater Lansing, Lansing

Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04879329

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon

Massive Bio SYNERGY-AI site, Lansing

Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil

Lòt etid nan Lansing

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.